Skip to main content

Global Nutraceutical CDMO Market: New Trends Driving Market Expansion and 8% CAGR by 2030

 


The nutraceutical CDMO market is anticipated to expand at a CAGR of ~8% during the forecast period. Key drivers of this growth include rising demand for nutraceutical products, technological advancements in manufacturing, shift towards plant-based and ayurvedic supplements, expanding nutraceutical applications, growing outsourcing trends in the nutraceutical industry, adoption of sedentary lifestyle & rising aging population, and increasing consumer focus on wellness and personalized nutrition.

A nutraceutical CDMO (Contract Development and Manufacturing Organization) is a company that provides outsourced services for the development, formulation, manufacturing, and packaging of nutraceutical products on behalf of brand owners and health supplement companies.

To request a free sample copy of this report, please visit below
https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/

Rising demand for nutraceutical products driving the growth of the nutraceutical CDMO market

Nutraceutical products encompass a wide range of substances and food items that offer medical or health benefits beyond basic nutrition, aiming to support disease prevention and treatment. As dietary habits evolve, the demand for these products continues to rise, driven by increasing consumer awareness, the growing prevalence of non-communicable diseases, and escalating healthcare costs. Additionally, the consumption of multivitamins is expected to surge as consumers prioritize immune system support, a trend that gained significant momentum during the COVID-19 pandemic and is likely to persist in the future. To meet these shifting consumer demands, nutraceutical companies are increasingly partnering with CDMOs for cost-effective, large-scale production, advanced R&D capabilities, and regulatory compliance. With stringent FDA and global regulations, CDMOs provide essential expertise in quality assurance, labeling, and clinical trials, ensuring that brands deliver high-quality, compliant products to market. The rapid expansion of e-commerce and direct-to-consumer (DTC) brands has further accelerated the need for private-label manufacturing and turnkey solutions. As the nutraceutical industry continues its rapid growth, CDMOs play a vital role in helping brands scale efficiently, develop innovative formulations, and cater to the increasing consumer demand for health and wellness solutions.

Growing outsourcing trends in the nutraceutical industry fuel its demand

Nutraceuticals and dietary ingredients such as probiotics, folic acid, and fish oil offer significant health benefits, including supporting biological processes that help prevent chronic diseases, promoting healthy aging, and maintaining the body's structure and function. As nutraceutical companies capitalize on this growing market, many are turning to specialized CDMOs with expertise in fine chemicals. CDMOs provide end-to-end solutions, including R&D, formulation, raw material sourcing, production, packaging, and labeling, allowing companies to focus on branding, marketing, and distribution while outsourcing manufacturing complexities. This approach helps streamline production, reduce costs, and enhance product quality while ensuring compliance with industry regulations. Key ways CDMOs support the growth of nutraceutical companies include reduced capital investment, regulatory compliance expertise, advanced manufacturing capabilities, and efficient development cycles.

Competitive Landscape Analysis

The global nutraceutical CDMO market is marked by the presence of established and emerging market players such as Catalent Inc.; Lonza; NutraScience Labs; Robinson Pharma, Inc.; Health Wright Products, Inc.; INPHARMA S.p.A.; Aenova Group; NutraPakUSA; SFI Health; Eurofins; WuXi AppTec; and Charles River Laboratories; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.

🔗 Want deeper insights? Download the sample report here:
https://meditechinsights.com/nutraceutical-cdmo-market/request-sample/

Market Segmentation

This report by Medi-Tech Insights provides the size of the global nutraceutical CDMO market at the regional- and country-level from 2023 to 2030. The report further segments the market based on dosage form, service type, and company size.

  • Market Size & Forecast (2023-2030), By Dosage Form, USD Million
    • Tablets & Capsules
    • Softgel
    • Powder
    • Others
  • Market Size & Forecast (2023-2030), By Service Type, USD Million
    • Product Formulation and Development
    • Research & Development (R&D)
    • Manufacturing and Packaging
    • Regulatory Compliance
    • Others
  • Market Size & Forecast (2023-2030), By Company Size, USD Million
    • Small Companies
    • Mid-Sized Companies
    • Large Companies
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
 Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Digital Pharmaceutical Supply Chain Management Market Sees Increasing Demand with 9% CAGR Until 2030

  The   digital pharmaceutical supply chain management market is projected to grow at a CAGR of 9% from 2025 to 2030.  The growth is driven by the increasing need for enhanced supply chain transparency, demand for temperature-sensitive drug handling, and the shift towards digitization in healthcare operations. However, the high implementation cost and data privacy concerns are notable restraints. The digital pharmaceutical supply chain management includes integration of advanced technologies like AI, blockchain, IoT, and data analytics into the pharmaceutical supply chain. This integration enhances transparency, efficiency, and traceability across sourcing, manufacturing, and distribution processes. The market is vital for ensuring drug safety, mitigating counterfeiting risks, and optimizing logistics. These solutions also aid in regulatory compliance by offering real-time insights and data for reporting. 🔗 Want deeper insights? Download the sample report here: h...
Post a Comment
Read more

Contrast Media APIs Market Evolving Healthcare Needs and Future Business Prospects CAGR 5% by 2030

  The global contrast media APIs market is set to witness a growth rate of 5% in the next 5 years.  Rising volume of diagnostic imaging procedures; technological advancements in imaging modalities; expansion of healthcare infrastructure in emerging markets; rising R&D investments to develop safer and more effective contrast agents, are some of the key factors driving the contrast media APIs market. Contrast media APIs are the primary compounds used in the formulation of contrast agents, which enhance the visibility of internal structures in diagnostic imaging. These APIs play a crucial role in modalities like  computed tomography  (CT),  magnetic resonance imaging  (MRI), and ultrasound by improving the differentiation between tissues, organs, and blood vessels. Typically derived from iodine or gadolinium, they are formulated to ensure solubility, stability, and patient safety during procedures. The manufacturing of contrast media APIs involves stric...
Post a Comment
Read more

Global Healthcare Payer Services Market: AI, Big Data & 8% CAGR Growth Forecast by 2030

  The healthcare payer services market is expected to grow at a CAGR of approximately 8% from 2025 to 2030.  Key drivers include the rising demand for cost-effective healthcare solutions, increased adoption of digital platforms, regulatory changes mandating operational transparency, the surge in healthcare data, and the growing need for fraud prevention mechanisms. However, challenges such as data security concerns and integration complexities act as significant restraints. The healthcare payer services market encompasses a range of administrative, operational, and financial services provided to healthcare payers, including insurance companies, government agencies, and employer groups. These services aim to enhance efficiency, reduce costs, and improve customer satisfaction. Offerings include claims processing, member management, provider management, and analytics for decision-making. The market leverages advanced technologies such as artificial intelligence and cloud compu...
Post a Comment
Read more